{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:50:20Z","timestamp":1790092220611,"version":"4.0.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"46","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,8]]},"DOI":"10.1093\/eurheartj\/ehaf531","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:11:46Z","timestamp":1752502306000},"page":"5059-5061","source":"Crossref","is-referenced-by-count":3,"title":["Cardiac magnetic resonance imaging in transthyretin amyloidosis: getting to the heart of the matter"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-6526","authenticated-orcid":false,"given":"Ahmad","family":"Masri","sequence":"first","affiliation":[{"name":"Amyloidosis Center, Division of Cardiology, School of Medicine, Oregon Health & Science University , 3181 SW Sam Jackson Rd, Portland, OR 97239 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"2025120718514030700_ehaf531-B1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/eurheartj\/ehae811","article-title":"Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine","volume":"46","author":"Gonzalez-Lopez","year":"2025","journal-title":"Eur Heart J"},{"key":"2025120718514030700_ehaf531-B2","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025120718514030700_ehaf531-B3","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"2025120718514030700_ehaf531-B4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ejhf.3138","article-title":"Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy","volume":"26","author":"Garcia-Pavia","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2025120718514030700_ehaf531-B5","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"key":"2025120718514030700_ehaf531-B6","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1093\/eurheartj\/ehaf412","article-title":"Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance","volume":"46","author":"Patel","year":"2025","journal-title":"Eur Heart J"},{"key":"2025120718514030700_ehaf531-B7","doi-asserted-by":"publisher","first-page":"e012135","DOI":"10.1161\/CIRCHEARTFAILURE.124.012135","article-title":"Effect of acoramidis on myocardial structure and function in transthyretin amyloid cardiomyopathy: insights from the ATTRibute-CM Cardiac Magnetic Resonance (CMR) substudy","volume":"17","author":"Razvi","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2025120718514030700_ehaf531-B8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025120718514030700_ehaf531-B9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4065\/80.5.611","article-title":"Postural pseudoanemia: posture-dependent change in hematocrit","volume":"80","author":"Jacob","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"2025120718514030700_ehaf531-B10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12968-018-0464-9","article-title":"Importance of standardizing timing of hematocrit measurement when using cardiovascular magnetic resonance to calculate myocardial extracellular volume (ECV) based on pre- and post-contrast T1 mapping","volume":"20","author":"Engblom","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025120718514030700_ehaf531-B11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11936-024-01049-z","article-title":"Advances in diagnosis and treatment of AL cardiac amyloidosis","volume":"26","author":"Sapru","year":"2024","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2025120718514030700_ehaf531-B12","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine (124I) evuzamitide (124I-p5 + 14): a phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025120718514030700_ehaf531-B13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using 124I-evuzamitide (124I-P5 + 14) versus 18F-florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025120718514030700_ehaf531-B14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0735-1097(25)01667-5","article-title":"Diagnostic performance of cardiac and whole-body 124I-evuzamitide (AT-01) PET\/MRI in systemic amyloidosis","volume":"85","author":"Masri","year":"2025","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/46\/5059\/64572408\/ehaf531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/46\/5059\/64572408\/ehaf531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T23:51:50Z","timestamp":1765151510000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/46\/5059\/8279687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":14,"journal-issue":{"issue":"46","published-online":{"date-parts":[[2025,10,9]]},"published-print":{"date-parts":[[2025,12,8]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf531","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,7]]},"published":{"date-parts":[[2025,10,9]]}}}